Centessa Pharmaceuticals plc (LON:0ACX)
London · Delayed Price · Currency is GBP · Price in USD 23.60
+0.40 (1.73%)
At close: Feb 12, 2026
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of 2.52 billion as of February 12, 2026. Its market cap has increased by 43.41% in one year.
Market Cap
2.52B
Enterprise Value
2.43B
Revenue
11.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.60
Market Cap Chart
Since May 28, 2021, Centessa Pharmaceuticals's market cap has increased from 1.34B to 2.52B, an increase of 88.14%. That is a compound annual growth rate of 14.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.52B | -7.08% |
| Dec 31, 2025 | 2.71B | 53.88% |
| Dec 31, 2024 | 1.76B | 189.13% |
| Dec 29, 2023 | 610.11M | 150.68% |
| Dec 30, 2022 | 243.38M | -67.44% |
| Dec 31, 2021 | 747.59M | -44.24% |
| May 28, 2021 | 1.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Primary Health Properties | 2.72B |
| Shaftesbury Capital | 2.71B |
| Pennon Group | 2.68B |
| QinetiQ Group | 2.54B |
| Shawbrook Group | 2.49B |
| International Workplace Group | 2.43B |
| Quilter | 2.41B |
| TBC Bank Group | 2.37B |